162 related articles for article (PubMed ID: 10455276)
1. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.
Mourtada M; Chan SL; Smith SA; Morgan NG
Br J Pharmacol; 1999 Jul; 127(5):1279-87. PubMed ID: 10455276
[TBL] [Abstract][Full Text] [Related]
2. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
Mourtada M; Smith SA; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415
[TBL] [Abstract][Full Text] [Related]
3. Insulinotropic activity of the imidazoline derivative RX871024 in the diabetic GK rat.
Efanov AM; Appelskog IB; Abdel-Halim SM; Khan A; Bränström R; Larsson O; Ostenson CG; Mest HJ; Berggren PO; Efendic S; Zaitsev SV
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E117-24. PubMed ID: 11739091
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
Chan SL; Mourtada M; Morgan NG
Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
[TBL] [Abstract][Full Text] [Related]
5. Imidazoline RX871024 raises diacylglycerol levels in rat pancreatic islets.
Efanov AM; Zaitsev SV; Berggren PO; Mest HJ; Efendic S
Biochem Biophys Res Commun; 2001 Mar; 281(5):1070-3. PubMed ID: 11243843
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
7. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
8. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery.
Zaitsev SV; Efanov AM; Efanova IB; Larsson O; Ostenson CG; Gold G; Berggren PO; Efendić S
Diabetes; 1996 Nov; 45(11):1610-8. PubMed ID: 8866568
[TBL] [Abstract][Full Text] [Related]
9. Effects of imidazoline derivative RX871024 on insulin, glucagon, and somatostatin secretion from isolated perfused rat pancreas.
Efanova IB; Zaitsev SV; Efanov AM; Ostenson C; Raap A; Mest H; Berggren P; Efendi
Biochem Biophys Res Commun; 1998 Nov; 252(1):162-5. PubMed ID: 9813163
[TBL] [Abstract][Full Text] [Related]
10. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
11. Different modes of action of the imidazoline compound RX871024 in pancreatic beta-cells. Blocking of K+ channels, mobilization of Ca2+ from endoplasmic reticulum, and interaction with exocytotic machinery.
Zaitsev SV; Efanov AM; Raap A; Efanova IB; Schloos J; Steckel-Hamann B; Larsson O; Ostenson CG; Berggren PO; Mest HJ; Efendic S
Ann N Y Acad Sci; 1999 Jun; 881():241-52. PubMed ID: 10415922
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
13. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
[TBL] [Abstract][Full Text] [Related]
14. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
15. The imidazoline RX871024 stimulates insulin secretion in pancreatic beta-cells from mice deficient in K(ATP) channel function.
Efanov AM; Høy M; Bränström R; Zaitsev SV; Magnuson MA; Efendic S; Gromada J; Berggren PO
Biochem Biophys Res Commun; 2001 Jun; 284(4):918-22. PubMed ID: 11409880
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretagogues with an imidazoline structure inhibit arginine-induced secretion from isolated glucagon secretion from isolated rat islets of Langerhans.
Mourtada M; Smith SA; Morgan NG
Biochem Biophys Res Commun; 1997 Jul; 236(1):162-6. PubMed ID: 9223445
[TBL] [Abstract][Full Text] [Related]
17. Two generations of insulinotropic imidazoline compounds.
Efendic S; Efanov AM; Berggren PO; Zaitsev SV
Diabetes; 2002 Dec; 51 Suppl 3():S448-54. PubMed ID: 12475789
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.
Brown CA; Loweth AC; Smith SA; Morgan NG
Br J Pharmacol; 1993 Feb; 108(2):312-7. PubMed ID: 8095415
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
Chan SL; Brown CA; Morgan NG
Eur J Pharmacol; 1993 Jan; 230(3):375-8. PubMed ID: 8095024
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
